Biomarker Lens

Common biomarkers

  • Hemoglobin
  • Glucose
  • ALT
  • Apolipoprotein B
  • C-Reactive Protein, Cardiac
  • Ferritin
  • Alb/Creat Ratio, Urine
  • Alkaline Phosphatase
  • FSH
  • T4,Free(Direct)

Biomarkers · Chemical

Infliximab Drug

Primary unit
ug/mL
LOINC codes
39803-2
Tests that measure Infliximab Drug
Quest Diagnostics 2, Labcorp 1

Ranges

Each lab publishes a reference range for the population groups it tests, usually the middle 95% of results. These intervals describe that population, not an optimal or healthy target. How ranges differ

Quest Diagnostics, Infliximab Level and Anti-Drug Antibody 36311

PopulationInterval
Infliximab LevelSee Laboratory Report
Infliximab Ab<38 AU/mL

Quest Diagnostics test catalog, 36311

Tests

Check the catalog code, specimen, method and preparation for every test that measures Infliximab Drug. Select up to five tests to compare them side by side.

Quest Diagnostics 2 tests

Single-analyte tests

  • Infliximab Level 36303

    Serum · Fasting not stated · Turnaround Set up: Tues; Report available: 2-8 days

    Method and collection
    Method
    Chemiluminescent Immunoassay
    Preparation
    Collect immediately before next scheduled dose (trough specimen)
    Reference notes
    See Laboratory Report
    Quest Diagnostics catalog page

Panels that include this biomarker

  • Infliximab Level and Anti-Drug Antibody 36311

    2 analytes · Serum · Fasting not stated

    Method and collection
    Method
    Chemiluminescent Immunoassay
    Preparation
    Dietary supplements containing biotin may interfere in assays and may skew results to be either falsely high or falsely low. For patients receiving the recommended daily doses of biotin, draw samples at least 8 hours following the last biotin supplementation. For patients on mega-doses of biotin supplements, draw samples at least 72 hours following the last biotin supplementation. Collect immediately before next scheduled dose (trough specimen).
    Quest Diagnostics catalog page

Labcorp 1 test

Panels that include this biomarker

  • Infliximab and Anti-Infliximab Antibody, Dose ASSURE™ IFX 503870

    2 analytes · Serum · Fasting not stated · Turnaround 5 - 10 days

    Method and collection
    Method
    Electrochemiluminescence Immunoassay (ECLIA)
    Collection
    Send serum in a plastic transport tube. To avoid delays in turnaround time when requesting multiple test on frozen samples, please submit separate frozen specimens for each test requested.
    Labcorp catalog page

0 of 5 tests selected

Pick one more

Sources

Verify these ranges and sources

We compile this page from named laboratory catalogs, guidelines and studies. Labs calculate reference intervals from the people they test, for one assay method and one population group, so an interval describes that population rather than an optimal target.

Interpret your own results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.